Drug Approval | September 09, 2021
Zydus Cadila gets US FDA approval for antidepressant tablets
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The company’s RenovoCath Delivery System designed for targeted treatment of solid tumours
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Subscribe To Our Newsletter & Stay Updated
